Not exact matches
The company's lead product candidate is amikacin liposome inhalation suspension, which is in late - state development for adult patients
with treatment refractory
nontuberculous mycobacteria lung disease caused by mycobacterium avium complex.
On October 13, 2016 a Centers for Disease Control (CDC) Health Advisory and Food & Drug Administration (FDA) Safety Communication announced that the Stöckert 3T heater / cooler devices by LivaNova PLC (formerly the Sorin Group) may have been contaminated
with Mycobacterium chimaera (M.Chimaera), a rare type
nontuberculous mycobacterium (NTM), during manufacturing.
On October 13, 2016 a Centers for Disease Control and Prevention (CDC) Health Advisory and Food and Drug Administration (FDA) Safety Communication announced that Stöckert 3T heater / cooler devices by LivaNova PLC (formerly the Sorin Group) may have been contaminated
with Mycobacterium chimaera (M. chimaera), a rare type of
nontuberculous mycobacterium (NTM), during manufacturing.